Correlation Between Algernon Pharmaceuticals and Roivant Sciences

Can any of the company-specific risk be diversified away by investing in both Algernon Pharmaceuticals and Roivant Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algernon Pharmaceuticals and Roivant Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Algernon Pharmaceuticals and Roivant Sciences, you can compare the effects of market volatilities on Algernon Pharmaceuticals and Roivant Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algernon Pharmaceuticals with a short position of Roivant Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algernon Pharmaceuticals and Roivant Sciences.

Diversification Opportunities for Algernon Pharmaceuticals and Roivant Sciences

-0.66

Correlation Coefficient

Algernon Pharmaceuticals  Roivant Sciences

Excellent diversification

The 3 months correlation between Algernon and Roivant is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Algernon Pharmaceuticals and Roivant Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roivant Sciences and Algernon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algernon Pharmaceuticals are associated (or correlated) with Roivant Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roivant Sciences has no effect on the direction of Algernon Pharmaceuticals i.e., Algernon Pharmaceuticals and Roivant Sciences go up and down completely randomly.

Pair Corralation between Algernon Pharmaceuticals and Roivant Sciences

Assuming the 90 days horizon Algernon Pharmaceuticals is expected to generate 20.54 times less return on investment than Roivant Sciences. In addition to that, Algernon Pharmaceuticals is 1.5 times more volatile than Roivant Sciences. It trades about 0.0 of its total potential returns per unit of risk. Roivant Sciences is currently generating about 0.09 per unit of volatility. If you would invest  156.00  in Roivant Sciences on September 24, 2024 and sell it today you would earn a total of  112.00  from holding Roivant Sciences or generate 71.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	28.06%
Values	Daily Returns

Algernon Pharmaceuticals  vs.  Roivant Sciences

Algernon Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Algernon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Roivant Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Roivant Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Roivant Sciences is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Algernon Pharmaceuticals and Roivant Sciences

The main advantage of trading using opposite Algernon Pharmaceuticals and Roivant Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algernon Pharmaceuticals position performs unexpectedly, Roivant Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roivant Sciences will offset losses from the drop in Roivant Sciences' long position.

The idea behind Algernon Pharmaceuticals and Roivant Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.